Gynecology Book

http://www.fpnotebook.com/

Mini-Pill

Aka: Mini-Pill, Progesterone only OCP, Micronor, Nor QD, Ovrette
  1. Mechanism
    1. Progesterone only (L/L/L)
      1. Low Progestational Activity
      2. Low Androgenic Activity
      3. Low Endometrial Activity
    2. No Estrogen
  2. Indications
    1. Age over 35 years old
    2. Intolerant to Estrogen Side effects
    3. Lactation
  3. Efficacy
    1. High failure rate compared with combination pills
    2. Better efficacy then barrier methods
    3. Failure rates
      1. Perfect use: 0.5% failure rate
      2. Typical use: 5% failure rate
  4. Adverse Effects
    1. Ectopic Pregnancy increased Incidence
    2. Breakthrough Menstrual Bleeding
      1. Consider switching to combination Oral Contraceptive
  5. Preparations
    1. Micronor (Norethindrone 0.35 mg)
    2. Nor-QD (Norethindrone 0.35 mg)
    3. Ovrette (dl-Norgestrel 0.075 mg)

Nor-QD (C0699165)

Concepts Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125)
MSH D009640
English Nor QD, Nor-Q.D., nor-qd, norqd, nor q d, nor qd, NorQD, Nor-QD
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Ovrette (C0699169)

Concepts Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125)
MSH D009644
English Norgestrel Wyeth Brand, Wyeth Brand of Norgestrel, Ovrette
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Micronor (C0699160)

Concepts Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125)
MSH D009640
English ortho micronor, micronor, Ortho Micronor, Micronor
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree